Virucidal efficacy of a novel silver-based disinfectant against SARS-CoV-2 Omicron BA.5

被引：0
作者：
Zani, Alberto [1 ]
Messali, Serena [1 ]
Caccuri, Francesca [1 ]
机构：
[1] Univ Brescia, Dept Mol & Translat Med, Sect Microbiol, Brescia, Italy
来源：
NEW MICROBIOLOGICA | 2023年 / 46卷 / 01期
关键词：
SARS-CoV-2; Omicron BA; 5; variant; disinfectants; Silver Barrier;
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
In this study we evaluated the antiviral activity of the Silver Barrier (R) disinfectant against SARS-CoV-2. Silver Barrier (R) showed time-and concentration-dependent antiviral activity against SARS-CoV-2. After 5 min contact time, Silver Barrier (R) at 0.002% showed a strong inhibitory effect (p < 0.001), with a 2-fold reduction of viral genome copy numbers, and a robust suppression (94%) of SARS-CoV-2 infectivity. Considering the effects obtained in solution and within a very short time, Silver Barrier (R) stands as an excellent new candidate for the disinfection of work environments, especially at the healthcare level, where there are people at high risk of serious illnesses.
引用
收藏
页码：60 / 64
页数：5
相关论文
共 50 条
  • [31] Epidemiologic Characteristics of SARS-CoV-2 Omicron BA.5.1.3 Variant and the Protection Provided By Inactivated Vaccination
    Li, Taoyuan
    Wu, Shaorong
    Tan, Jiaxiong
    Huang, Zhengyi
    Li, Lijun
    Luo, Wenzhi
    Wu, Yayun
    Lyu, Jun
    Liang, Xujing
    VIRAL IMMUNOLOGY, 2023, 36 (08) : 544 - 549
  • [32] Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone
    da Silva, Eveline Santos
    Kohnen, Michel
    Gilson, Georges
    Staub, Therese
    Arendt, Victor
    Hilger, Christiane
    Servais, Jean-Yves
    Charpentier, Emilie
    Domingues, Olivia
    Snoeck, Chantal J.
    Ollert, Markus
    Seguin-Devaux, Carole
    Perez-Bercoff, Danielle
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [33] Assessment of antibody responses against SARS-CoV-2 in unvaccinated individuals and vaccinees from Omicron-BA.2 infection in Zhaoqing, Guangdong Province, China
    Zhang, Huan
    Jiang, Yushan
    Tan, Hanqing
    Zou, Lirong
    Zheng, Zhonghua
    Huang, Yushi
    Lin, Shujian
    Su, Lebin
    Yu, Jianxiang
    Deng, Xiaoling
    He, Jianfeng
    Liu, Chang
    Shen, Chenguang
    Li, Baisheng
    VIROLOGY JOURNAL, 2022, 19 (01)
  • [34] SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia
    Cheng, Fang
    Xiang, Hang
    Gale, Robert Peter
    Chen, Siyi
    Qu, Jiao
    Guo, Hao
    Li, Qiubai
    Zhang, Yanli
    Li, Weiming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 11025 - 11030
  • [35] Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies
    Zhou, Hao
    Dcosta, Belinda M.
    Landau, Nathaniel R.
    Tada, Takuya
    VIRUSES-BASEL, 2022, 14 (06):
  • [36] Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice
    Wang, Yudong
    Wang, Busen
    Zhao, Zhenghao
    Xu, Jinghan
    Zhang, Zhe
    Zhang, Jinlong
    Chen, Yi
    Song, Xiaohong
    Zheng, Wanru
    Hou, Lihua
    Wu, Shipo
    Chen, Wei
    VIRUSES-BASEL, 2023, 15 (03):
  • [37] Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study
    Aoki, Akira
    Adachi, Hirokazu
    Mori, Yoko
    Ito, Miyabi
    Sato, Katsuhiko
    Okuda, Kenji
    Sakakibara, Toru
    Okamoto, Yoshinori
    Jinno, Hideto
    MICROBIOLOGY SPECTRUM, 2022, 10 (04):
  • [38] Estimating the incubation period of SARS-CoV-2 Omicron BA.1 variant in comparison with that during the Delta variant dominance in South Korea
    Liu, Yanwen
    Zhao, Shi
    Ryu, Sukhyun
    Ran, Jinjun
    Fan, Junhua
    He, Daihai
    ONE HEALTH, 2022, 15
  • [39] Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
    Selvavinayagam, Sivaprakasam T.
    Yong, Yean Kong
    Joseph, Narcisse
    Hemashree, Kannan
    Tan, Hong Yien
    Zhang, Ying
    Rajeshkumar, Manivannan
    Kumaresan, Anandhazhvar
    Kalpana, Raghu
    Kalaivani, Vasudevan
    Monika, Ayyagari Venkata Devi
    Suvaithenamudhan, Suvaiyarasan
    Kannan, Meganathan
    Murugesan, Amudhan
    Narayanasamy, Krishnasamy
    Palani, Sampath
    Larsson, Marie
    Shankar, Esaki M.
    Raju, Sivadoss
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [40] Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
    Branche, Angela R.
    Rouphael, Nadine G.
    Losada, Cecilia
    Baden, Lindsey R.
    Anderson, Evan J.
    Luetkemeyer, Anne F.
    Diemert, David J.
    Winokur, Patricia L.
    Presti, Rachel M.
    Kottkamp, Angelica C.
    Falsey, Ann R.
    Frey, Sharon E.
    Rupp, Richard
    Baecker, Martin
    Novak, Richard M.
    Walter, Emmanuel B.
    Jackson, Lisa A.
    Little, Susan J.
    Immergluck, Lilly C.
    Mahgoub, Siham M.
    Whitaker, Jennifer A.
    Babu, Tara M.
    Goepfert, Paul A.
    Fusco, Dahlene N.
    Atmar, Robert L.
    Posavad, Christine M.
    Netzl, Antonia
    Smith, Derek J.
    Telu, Kalyani
    Mu, Jinjian
    Makowski, Mat
    Makhene, Mamodikoe K.
    Crandon, Sonja
    Montefiori, David C.
    Roberts, Paul C.
    Beigel, John H.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (04) : 560 - 564
12345